Page last updated: 2024-09-03

morphiceptin, n-me-phe(3)- and colforsin

morphiceptin, n-me-phe(3)- has been researched along with colforsin in 1 studies

Compound Research Comparison

Studies
(morphiceptin, n-me-phe(3)-)
Trials
(morphiceptin, n-me-phe(3)-)
Recent Studies (post-2010)
(morphiceptin, n-me-phe(3)-)
Studies
(colforsin)
Trials
(colforsin)
Recent Studies (post-2010) (colforsin)
951113,460461,298

Protein Interaction Comparison

ProteinTaxonomymorphiceptin, n-me-phe(3)- (IC50)colforsin (IC50)
nuclear receptor subfamily 0 group B member 1Homo sapiens (human)1.729
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.041
Adenylate cyclase type 1Homo sapiens (human)0.0955

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Law, PY; Prather, PL; Tsai, AW1

Other Studies

1 other study(ies) available for morphiceptin, n-me-phe(3)- and colforsin

ArticleYear
Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:1

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Analgesics; Cell Differentiation; Colforsin; Cyclic AMP; Endorphins; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Humans; Neuroblastoma; Neurons; Receptors, Opioid, delta; Receptors, Opioid, mu; Sensitivity and Specificity; Signal Transduction; Stimulation, Chemical; Tumor Cells, Cultured

1994